- call +1-201-465-4211
- email sales@mrinsights.biz
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
Scope of the Report:
This report focuses on the Companion Animal Speciality Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
By the end of 2025, the Veterinary Clinics segment is projected to reach more than US$ 21 Bn or more than 45% share of the total market, expanding at a CAGR of 5.8% over the forecast period.
The worldwide market for Companion Animal Speciality Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Zoetis
Merck
Bayer
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibiotics
Anti-inflammatory Drugs
Parasiticides
Heartworm
Behavioural Products
Nutritional Products
Anti-Obesity Drugs
Skin Care Products
Vaccines
Market Segment by Applications, can be divided into
Hospital
Clinic
Others
There are 15 Chapters to deeply display the global Companion Animal Speciality Drugs market.
Chapter 1, to describe Companion Animal Speciality Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Companion Animal Speciality Drugs, with sales, revenue, and price of Companion Animal Speciality Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Companion Animal Speciality Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Companion Animal Speciality Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Companion Animal Speciality Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Companion Animal Speciality Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Antibiotics
1.2.2 Anti-inflammatory Drugs
1.2.3 Parasiticides
1.2.4 Heartworm
1.2.5 Behavioural Products
1.2.6 Nutritional Products
1.2.7 Anti-Obesity Drugs
1.2.8 Skin Care Products
1.2.9 Vaccines
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Zoetis
2.1.1 Business Overview
2.1.2 Companion Animal Speciality Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Zoetis Companion Animal Speciality Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Companion Animal Speciality Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Companion Animal Speciality Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Companion Animal Speciality Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Companion Animal Speciality Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Elanco
2.4.1 Business Overview
2.4.2 Companion Animal Speciality Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Elanco Companion Animal Speciality Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Companion Animal Speciality Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Companion Animal Speciality Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ceva Sante Animale
2.6.1 Business Overview
2.6.2 Companion Animal Speciality Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ceva Sante Animale Companion Animal Speciality Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Companion Animal Speciality Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Companion Animal Speciality Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Companion Animal Speciality Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Companion Animal Speciality Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Companion Animal Speciality Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Companion Animal Speciality Drugs Market Analysis by Regions
4.1 Global Companion Animal Speciality Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Companion Animal Speciality Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Companion Animal Speciality Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
4.5 South America Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
5 North America Companion Animal Speciality Drugs by Countries
5.1 North America Companion Animal Speciality Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Companion Animal Speciality Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Companion Animal Speciality Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
6 Europe Companion Animal Speciality Drugs by Countries
6.1 Europe Companion Animal Speciality Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Companion Animal Speciality Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Companion Animal Speciality Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
6.3 UK Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
6.4 France Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Companion Animal Speciality Drugs by Countries
7.1 Asia-Pacific Companion Animal Speciality Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Companion Animal Speciality Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Companion Animal Speciality Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
7.5 India Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
8 South America Companion Animal Speciality Drugs by Countries
8.1 South America Companion Animal Speciality Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Companion Animal Speciality Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Companion Animal Speciality Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Companion Animal Speciality Drugs by Countries
9.1 Middle East and Africa Companion Animal Speciality Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Companion Animal Speciality Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Companion Animal Speciality Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Companion Animal Speciality Drugs Sales and Growth Rate (2013-2018)
10 Global Companion Animal Speciality Drugs Market Segment by Type
10.1 Global Companion Animal Speciality Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Companion Animal Speciality Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Companion Animal Speciality Drugs Revenue and Market Share by Type (2013-2018)
10.2 Antibiotics Sales Growth and Price
10.2.1 Global Antibiotics Sales Growth (2013-2018)
10.2.2 Global Antibiotics Price (2013-2018)
10.3 Anti-inflammatory Drugs Sales Growth and Price
10.3.1 Global Anti-inflammatory Drugs Sales Growth (2013-2018)
10.3.2 Global Anti-inflammatory Drugs Price (2013-2018)
10.4 Parasiticides Sales Growth and Price
10.4.1 Global Parasiticides Sales Growth (2013-2018)
10.4.2 Global Parasiticides Price (2013-2018)
10.5 Heartworm Sales Growth and Price
10.5.1 Global Heartworm Sales Growth (2013-2018)
10.5.2 Global Heartworm Price (2013-2018)
10.6 Behavioural Products Sales Growth and Price
10.6.1 Global Behavioural Products Sales Growth (2013-2018)
10.6.2 Global Behavioural Products Price (2013-2018)
10.7 Nutritional Products Sales Growth and Price
10.7.1 Global Nutritional Products Sales Growth (2013-2018)
10.7.2 Global Nutritional Products Price (2013-2018)
10.8 Anti-Obesity Drugs Sales Growth and Price
10.8.1 Global Anti-Obesity Drugs Sales Growth (2013-2018)
10.8.2 Global Anti-Obesity Drugs Price (2013-2018)
10.9 Skin Care Products Sales Growth and Price
10.9.1 Global Skin Care Products Sales Growth (2013-2018)
10.9.2 Global Skin Care Products Price (2013-2018)
10.10 Vaccines Sales Growth and Price
10.10.1 Global Vaccines Sales Growth (2013-2018)
10.10.2 Global Vaccines Price (2013-2018)
11 Global Companion Animal Speciality Drugs Market Segment by Application
11.1 Global Companion Animal Speciality Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Companion Animal Speciality Drugs Market Forecast (2018-2023)
12.1 Global Companion Animal Speciality Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Companion Animal Speciality Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Companion Animal Speciality Drugs Market Forecast (2018-2023)
12.2.2 Europe Companion Animal Speciality Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Companion Animal Speciality Drugs Market Forecast (2018-2023)
12.2.4 South America Companion Animal Speciality Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Companion Animal Speciality Drugs Market Forecast (2018-2023)
12.3 Companion Animal Speciality Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Companion Animal Speciality Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Companion Animal Speciality Drugs Market Share Forecast by Type (2018-2023)
12.4 Companion Animal Speciality Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Companion Animal Speciality Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Companion Animal Speciality Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Companion Animal Speciality Drugs Picture
Table Product Specifications of Companion Animal Speciality Drugs
Figure Global Sales Market Share of Companion Animal Spec
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
